GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taisho Pharmaceutical Holdings Co Ltd (TSE:4581) » Definitions » Forward PE Ratio

Taisho Pharmaceutical Holdings Co (TSE:4581) Forward PE Ratio : 0.00 (As of May. 15, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Taisho Pharmaceutical Holdings Co Forward PE Ratio?

Taisho Pharmaceutical Holdings Co's Forward PE Ratio for today is 0.00.

Taisho Pharmaceutical Holdings Co's PE Ratio without NRI for today is 0.00.

Taisho Pharmaceutical Holdings Co's PE Ratio for today is 0.00.


Taisho Pharmaceutical Holdings Co Forward PE Ratio Historical Data

The historical data trend for Taisho Pharmaceutical Holdings Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taisho Pharmaceutical Holdings Co Forward PE Ratio Chart

Taisho Pharmaceutical Holdings Co Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-07
Forward PE Ratio
31.45 23.64 33.56 36.36 39.37 36.76

Taisho Pharmaceutical Holdings Co Quarterly Data
2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03
Forward PE Ratio 33.44 18.35 19.65 31.45 30.12 22.17 21.01 23.64 19.80 19.46 40.49 33.56 35.97 40.00 45.05 36.36 42.74 37.59 37.59 39.37 37.45

Competitive Comparison of Taisho Pharmaceutical Holdings Co's Forward PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Taisho Pharmaceutical Holdings Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Taisho Pharmaceutical Holdings Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Taisho Pharmaceutical Holdings Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Taisho Pharmaceutical Holdings Co's Forward PE Ratio falls into.



Taisho Pharmaceutical Holdings Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Taisho Pharmaceutical Holdings Co  (TSE:4581) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Taisho Pharmaceutical Holdings Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Taisho Pharmaceutical Holdings Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Taisho Pharmaceutical Holdings Co (TSE:4581) Business Description

Traded in Other Exchanges
Address
3-24-1 Takada, Toshima-ku, Tokyo, JPN, 170-8655
Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, Self-Medication and Prescription Pharmaceuticals. The vast majority of Taisho's revenue is derived from its Self-Medication segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. The vast majority of sales are generated by sales to external customers in Japan.

Taisho Pharmaceutical Holdings Co (TSE:4581) Headlines

No Headlines